Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth
Saffar, M.J.; Rezai, M.S.
Indian Pediatrics 41(12): 1232-1237
2004
ISSN/ISBN: 0019-6061 PMID: 15623904 Document Number: 239859
Four hundred and fifty three healthy children immunized with a course of hepatitis B vaccine beginning at birth were tested at 10-11 years of age for persistence of anti-hepatitis B-S antigen antibody (anti-HBs); and responses of children without protective antibody to different doses of hepatitis B vaccine booster were evaluated. Although nearly 42% of them were not seroprotected, but most of boosted subjects (87.3%) retained robust immunologic memory and rapidly retained a protective anti-HBs antibody titer of at least 10 IU/L after booster vaccination.
Document emailed within 1 workday
Related Documents
Jafarzadeh, A.; Montazerifar, S.J. 2006: Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth Journal of Ayub Medical College Abbottabad: Jamc 18(4): 4-9Corbella, E.; Garghetti, L.; Poloniato, A.; Zambelloni, C.; Consonni, A. 1987: Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses Minerva Pediatrica 39(20): 821-826
Dolezalová, K.; Procházková, J.; Chýlková, V.; Turková, M.; Opravilová, H.; Zaydlar, K. 1987: Immunologic response in children treated with long-term bacterial autovaccination Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 30(5): 615-635
Ferreira, C.R.; Yoshida, C.F.; Mercadante, L.A.; Gomes, D.F.; Oliveira, J.M.; França, M.S.; Sidoni, M.; Ennes, I.C.; Baptista, M.L.; Schatzmayr, H.G. 1993: Immunization against hepatitis B in children from endemic zone: evaluation of the antibody response against the DNA recombinant vaccine (Engerix B-20 MCG) Revista do Instituto de Medicina Tropical de Sao Paulo 35(1): 89-92
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
McIntyre, A.; Nimmo, G.R.; Wood, G.M.; Tinniswood, R.D.; Kerlin, P. 1992: Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Australian and New Zealand Journal of Medicine 22(1): 19-22
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Petry, L.J.; Weems, L.B.; Livingstone, J.N. 1991: Relationship of stress, distress, and the immunologic response to a recombinant hepatitis B vaccine Journal of Family Practice 32(5): 481-486
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Watanaveeradej, V.; Samakoses, R.; Kerdpanich, A.; Aree, C.; Nitayabhan, S.; Viputtikul, K.; Sukwit, S. 2002: Antibody response to hepatitis B vaccine in infants of HIV-positive mothers International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(3): 240-241
Migneco, G.; Tripi, S.; Navetta, A.; La Ferla, A.; Vaccaro, F. 1990: Serum zinc concentration and antibody response to hepatitis B vaccine in hemodialysis patients Minerva Medica 81(1-2): 19-21
Wiese, M.; Haupt, R. 1986: Long-term analysis of non-A, non-B hepatitis--clinical, histologic and immunologic findings Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 46(2): 103-112
Sabin, A.B.; Flores Arechiga, A.; Fernández de Castro, J.; Albrecht, P.; Sever, J.L.; Shekarchi, I. 1984: Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response JAMA 251(18): 2363-2371
Inskip, H.M.; Hall, A.J.; Chotard, J.; Loik, F.; Whittle, H. 1991: Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response International Journal of Epidemiology 20(3): 764-769
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Chiu, S.Y.; Gonq, J.H.; Lee, C.H. 1975: Immune response during hyperimmunization: (XII) Long term skin-binding antibody in comparison with the ordinary passive cutaneous anaphylaxis (PCA) antibody in immune sera Journal of the Formosan Medical Association 74(9): 613-619
Gnanashanmugam, D.; Troy, S.B.; Musingwini, G.; Huang, C.; Halpern, M.S.; Stranix-Chibanda, L.; Shetty, A.K.; Kouiavskaia, D.; Nathoo, K.; Chumakov, K.; Maldonado, Y.A. 2012: Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children Pediatric Infectious Disease Journal 31(2): 176-180
Juszczyk, J.; Barałkiewicz, G. 1992: Long term results of vaccination against viral hepatitis B using recombinant vaccine Engerix B Przeglad Epidemiologiczny 46(4): 271-279
Yoshida, F.T.; Takahashi, C.; Mercadante, L.A.; Camargo, I.F.; Schatzmayr, H.G. 1988: Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up Revista do Instituto de Medicina Tropical de Sao Paulo 30(1): 11-16
Nash, D.; Katyal, M.; Brinkhof, M.W.G.; Keiser, O.; May, M.; Hughes, R.; Dabis, F.; Wood, R.; Sprinz, E.; Schechter, M.; Egger, M. 2008: Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies Aids 22(17): 2291-2302